Investor Education Series
The KC BioHub Investor Education Series is an initiative developed by KC BioHub to support individuals interested in learning more about early-stage investment in life sciences, biotechnology, and related fields.
Designed for accredited angel investors, the program offers a guided introduction to the biotech ecosystem, covering scientific concepts, regulatory processes, due diligence practices, and market trends. Sessions are supported by experienced practitioners, researchers, and investors with direct knowledge of the field.
Whether you’re looking to expand your portfolio or deepen your understanding of emerging technologies in healthcare, agriculture, and bioengineering, this series offers an accessible way to get started.
What the Program Offers
- A foundational overview of biotech, life sciences, and agtech investing
- Live instruction from subject matter experts with real-world experience
- Opportunities for discussion and Q&A in each session
- Optional access to pitch events, lab tours, and networking with regional companies
- A growing peer community interested in science-backed innovation and regional economic growth
Who Should Participate?
This program is intended for accredited angel investors.
Participants do not need prior biotech experience, just curiosity, openness to learning, and an interest in engaging with Kansas City’s growing life sciences ecosystem. The program is open to investors based locally or internationally.
Spring 2026 Curriculum
Apr 2, 2026 – Angel Investing: Why Biotech?
Historical and conceptual grounding in bioscience as an investable asset class and the role of angel investors in translating research into real-world solutions.
Apr 9, 2026 – Life Sciences: A Varied Investment Opportunity
Overview of major life sciences subsectors—including agtech, medical biotech, biotools, bioindustrials, and digital health—with emphasis on market potential and risk profiles.
Apr 16, 2026 – Due Diligence: A Guide for Life Sciences Companies
A structured framework for evaluating scientific validity, IP strength, regulatory feasibility, management quality, and financial readiness.
Apr 23, 2026 – Regulation: Navigating for Investing in Life Sciences
Understanding U.S. and global regulatory frameworks (FDA, USDA, EPA, EMA) and how regulatory strategy impacts timelines, costs, and investment theses.
Apr 30, 2026 – Managing Risk: How Biotech Fits in Your Broader Portfolio
Portfolio construction, position sizing, exit expectations, and the strategic use of tools like Kansas Angel Tax Credits and tax-loss harvesting.
May 7, 2026 – Dealflow, Collaboration & Next Steps
Applying the framework in practice, engaging with KC BioHub dealflow, co-investing, shared diligence, and continued participation through investor meetups.
